IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 160 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $23,122,000 | +26.6% | 2,030,000 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $18,260,000 | -12.8% | 2,030,000 | 0.0% | 0.00% | -20.0% |
Q2 2020 | $20,950,000 | +2.3% | 2,030,000 | 0.0% | 0.01% | -16.7% |
Q1 2020 | $20,483,000 | -24.2% | 2,030,000 | 0.0% | 0.01% | 0.0% |
Q4 2019 | $27,019,000 | +55.0% | 2,030,000 | 0.0% | 0.01% | +50.0% |
Q3 2019 | $17,428,000 | -21.5% | 2,030,000 | 0.0% | 0.00% | -20.0% |
Q2 2019 | $22,208,000 | -19.1% | 2,030,000 | 0.0% | 0.01% | -28.6% |
Q1 2019 | $27,466,000 | +30.6% | 2,030,000 | 0.0% | 0.01% | +16.7% |
Q4 2018 | $21,031,000 | -43.9% | 2,030,000 | 0.0% | 0.01% | -33.3% |
Q3 2018 | $37,474,000 | -3.5% | 2,030,000 | 0.0% | 0.01% | +12.5% |
Q2 2018 | $38,814,000 | +23.9% | 2,030,000 | 0.0% | 0.01% | +14.3% |
Q1 2018 | $31,323,000 | +57.1% | 2,030,000 | +52.6% | 0.01% | +75.0% |
Q4 2017 | $19,937,000 | -4.9% | 1,330,000 | 0.0% | 0.00% | -20.0% |
Q3 2017 | $20,974,000 | -16.5% | 1,330,000 | 0.0% | 0.01% | -16.7% |
Q2 2017 | $25,110,000 | +10.7% | 1,330,000 | 0.0% | 0.01% | +20.0% |
Q1 2017 | $22,690,000 | +47.6% | 1,330,000 | -9.8% | 0.01% | 0.0% |
Q3 2015 | $15,370,000 | -13.6% | 1,475,000 | 0.0% | 0.01% | 0.0% |
Q2 2015 | $17,789,000 | -24.6% | 1,475,000 | 0.0% | 0.01% | -16.7% |
Q1 2015 | $23,600,000 | -4.0% | 1,475,000 | -8.1% | 0.01% | -14.3% |
Q4 2014 | $24,589,000 | +18.3% | 1,605,000 | 0.0% | 0.01% | +16.7% |
Q3 2014 | $20,793,000 | -15.5% | 1,605,000 | 0.0% | 0.01% | -14.3% |
Q2 2014 | $24,605,000 | +21.0% | 1,605,000 | -2.7% | 0.01% | +16.7% |
Q1 2014 | $20,328,000 | -12.2% | 1,650,000 | -17.3% | 0.01% | -14.3% |
Q4 2013 | $23,162,000 | -2.0% | 1,995,000 | 0.0% | 0.01% | 0.0% |
Q3 2013 | $23,641,000 | -18.8% | 1,995,000 | -31.8% | 0.01% | -22.2% |
Q2 2013 | $29,104,000 | – | 2,925,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 16,390,000 | $191,107,000 | 16.54% |
HealthInvest Partners AB | 730,000 | $8,512,000 | 11.99% |
13D Management LLC | 612,853 | $7,146,000 | 2.74% |
Brown Capital Management | 16,257,899 | $189,567,000 | 1.57% |
BRIDGER MANAGEMENT, LLC | 929,714 | $10,840,000 | 1.40% |
Camber Capital Management LP | 3,000,000 | $34,980,000 | 1.20% |
Intrinsic Value Partners, LLC | 55,057 | $642,000 | 0.68% |
PRICE MICHAEL F | 520,000 | $6,063,000 | 0.67% |
CLARK ESTATES INC/NY | 355,000 | $4,139,000 | 0.61% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 8,145,674 | $94,979,000 | 0.56% |